Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
EELvrgPZ7qP26rn4
Listen
